Global Genomic Data Analysis and Interpretation Market (2020 to 2030) - Focus on Products, Genomic Platforms, Applications, End-users, Country Data and Competitive Landscape
February 08, 2021 07:58 ET
|
Research and Markets
Dublin, Feb. 08, 2021 (GLOBE NEWSWIRE) -- The "Global Genomic Data Analysis and Interpretation Market: Focus on Products, Genomic Platforms, Applications, End Users, Country Data (15 Countries), and...
Insights on the Precision Medicine Global Market to 2027 - Featuring Thermo Fisher Scientific, AstraZeneca & Pfizer Among Others
February 02, 2021 05:33 ET
|
Research and Markets
Dublin, Feb. 02, 2021 (GLOBE NEWSWIRE) -- The "Precision Medicine Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The precision medicine market is...
Dr. Jennifer Levin Carter Joins Advisory Board of Novel Precision Oncology Platform Creator 4D Path
December 15, 2020 10:00 ET
|
4D Path
NEWTON, Mass., Dec. 15, 2020 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, is pleased to announce that Jennifer Levin Carter,...
PMV Pharmaceuticals to Present at Evercore ISI 3rd Annual HealthCONx Conference
November 24, 2020 17:00 ET
|
PMV Pharmaceuticals, Inc.
CRANBURY, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...
PMV Pharma Doses First Patient in Phase 1/2 Study of PC14586, a First-in-Class Precision Oncology Therapy That Targets Mutant p53
November 23, 2020 08:00 ET
|
PMV Pharmaceuticals, Inc.
PC14586 targets p53 Y220C mutants to selectively reactivate p53, restoring the protein’s tumor-suppressing functionPhase 1/2 study is enrolling patients with advanced solid tumors that have a p53...
FDA Grants Breakthrough Designation to 4D Path for Novel Cancer Diagnostic Solution
November 18, 2020 10:00 ET
|
4D Path
NEWTON, Mass., Nov. 18, 2020 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, today announced that the U.S. Food & Drug...
4D Path Announces Patented Precision Oncology Platform for Instant Biomarker Profiling and Stratification Just From H&E Biopsy or Resection Images
November 12, 2020 10:00 ET
|
4D Path
NEWTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- 4D Path, a company conceived by an experienced team of scientists, clinicians and management from leading research institutions including MIT,...
Notable to Host July 23 Webinar with Stanford Cancer Institute and MDS Foundation: Emerging Treatment Approaches for Higher Risk Myelodysplastic Syndromes
July 13, 2020 11:00 ET
|
Notable Labs
FOSTER CITY, Calif., July 13, 2020 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, announced today...
Notable Appoints Biotech Veteran Joseph Wagner PhD as Chief Scientific Officer
July 08, 2020 11:00 ET
|
Notable Labs
FOSTER CITY, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, announced today...
Stanford study finds that Notable’s drug sensitivity screening platform can identify potentially useful drugs for MDS patients refractory to standard therapies
June 23, 2020 11:00 ET
|
Notable Labs
FOSTER CITY, Calif., June 23, 2020 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, announced today...